Addus HomeCare (ADUS) Expected to Announce Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) is expected to be announcing its Q4 2025 results before the market opens on Monday, February 23rd. Analysts expect the company to announce earnings of $1.71 per share for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 9:00 AM ET.

Addus HomeCare Stock Up 1.3%

ADUS stock opened at $113.80 on Monday. The stock has a fifty day moving average of $109.72 and a 200-day moving average of $112.94. Addus HomeCare has a fifty-two week low of $88.96 and a fifty-two week high of $124.43. The company has a market capitalization of $2.10 billion, a price-to-earnings ratio of 24.37, a PEG ratio of 1.37 and a beta of 0.91. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66.

Insider Transactions at Addus HomeCare

In other news, EVP Darby Anderson sold 20,000 shares of the business’s stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the completion of the transaction, the executive vice president directly owned 44,144 shares in the company, valued at $4,811,696. The trade was a 31.18% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last 90 days, insiders have sold 20,316 shares of company stock valued at $2,215,998. Corporate insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently added to or reduced their stakes in the business. CANADA LIFE ASSURANCE Co grew its position in Addus HomeCare by 0.6% during the second quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock worth $2,150,000 after buying an additional 106 shares in the last quarter. State of Wyoming boosted its position in shares of Addus HomeCare by 25.7% during the 4th quarter. State of Wyoming now owns 523 shares of the company’s stock valued at $56,000 after acquiring an additional 107 shares during the last quarter. Pathstone Holdings LLC grew its holdings in shares of Addus HomeCare by 0.9% during the third quarter. Pathstone Holdings LLC now owns 12,727 shares of the company’s stock worth $1,502,000 after purchasing an additional 112 shares in the last quarter. Larson Financial Group LLC grew its holdings in shares of Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its position in shares of Addus HomeCare by 1.4% in the second quarter. Thrivent Financial for Lutherans now owns 13,350 shares of the company’s stock worth $1,538,000 after purchasing an additional 179 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ADUS. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the stock a “buy” rating in a research report on Wednesday, January 7th. Royal Bank Of Canada upped their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a research note on Friday, November 7th. Wall Street Zen downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday. BMO Capital Markets started coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price objective for the company. Finally, Barclays increased their target price on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $135.44.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.